Use of newborn dried bloodspots in research; harmonization of regulations and/or guidelines for human subjects research; Health Insurance Portability and Accountability Act (HIPAA) and Clinical Laboratory Improvement Amendments (CLIA) issues with individual research results; and pediatric studies for drugs and biologics
Read MoreMAR 23-24 PEDAC
Sedation in Pediatric Clinical Trials and Drugs Required for Review Under BPCA/PREA/PMDSIA
Read MoreMAR 24-25 SACHRP
Use of newborn dried bloodspots in research; harmonization of regulations and/or guidelines for human subjects research; Health Insurance Portability and Accountability Act (HIPAA) and Clinical Laboratory Improvement Amendments (CLIA) issues with individual research results; and pediatric studies for drugs and biologics
Read MoreMAR 23-24 PEDAC
Sedation in Pediatric Clinical Trials and Drugs Required for Review Under BPCA/PREA/PMDSIA
Read MoreNOV 19 SBFDA
Potential toxicity of anesthetics and sedation drugs in the pediatric population
Read MoreNOV 19 SBFDA
Potential toxicity of anesthetics and sedation drugs in the pediatric population
Read MoreNOV 19 SBFDA
Potential toxicity of anesthetics and sedation drugs in the pediatric population
Read More